Jeff Potts, a seasoned technology expert with over 12 years of experience in industrial R&D and product development, has been appointed as the Chief Technology Officer of Xironetic, a provider of augmented reality surgical guidance technology. Dr. Christian El-Amm, Founder and Executive Chairman of Xironetic, expressed excitement about Jeff’s selection, given the company’s growing clinical adoption by surgeons worldwide.
Before joining Xironetic, Jeff led a global team at Baker Hughes focused on new product development using artificial intelligence and augmented reality. With a Ph.D. from The University of Texas at Austin and 15 filed or granted patents to his name, Jeff brings a wealth of knowledge and expertise to his new role. He is thrilled about the opportunity to lead Xironetic’s technology efforts and believes that the technology developed at the company has the potential to transform computer-aided surgery and become the standard of care in the future.
Xironetic specializes in building augmented reality solutions for surgical guidance. Their IntraOpVSP software, which combines augmented reality and computer vision, has been used in over 160 surgical cases and received FDA clearance in 2022. To learn more about Xironetic’s advancements in surgical technology or connect with them on LinkedIn, visit http://www.xironetic.com.
